End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
103.5 TWD | 0.00% | -1.43% | -23.05% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
60.9
%
| - | - | 348 | 60.9 % | - |
Health Product
41.5
%
| 341 | 97.4 % | 237 | 41.5 % | -30.67% |
Other
-2.4
%
| 2 | 0.5 % | -14 | -2.4 % | -918.21% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
100.0
%
| 343 | 97.8 % | 571 | 100.0 % | +66.58% |
Others
0.0
%
| 8 | 2.2 % | 0 | 0.0 % | -97.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chia Yueh Pan
CEO | Chief Executive Officer | - | 10-12-31 |
Yuan Chang Cheng
DFI | Director of Finance/CFO | - | 14-03-13 |
Tzu Ming Pan
CTO | Chief Tech/Sci/R&D Officer | - | 16-06-06 |
Teng Hsien Tseng
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Lee
CHM | Chairman | 73 | 07-09-03 |
Ching Yi Wang
BRD | Director/Board Member | 83 | 20-11-30 |
Hsu Chih Hsu
BRD | Director/Board Member | - | 16-06-06 |
Tzu Ming Pan
CTO | Chief Tech/Sci/R&D Officer | - | 16-06-06 |
Chia Yueh Pan
CEO | Chief Executive Officer | - | 10-12-31 |
Yan Lien
BRD | Director/Board Member | - | 20-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 59,389,066 | 28,550,222 ( 48.07 %) | 0 | 48.07 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-23.05% | 189M | |
+12.97% | 8.27B | |
+3.37% | 7.47B | |
-15.13% | 5.23B | |
-10.23% | 3.62B | |
-19.61% | 3.26B | |
-12.98% | 1.22B | |
-31.23% | 1.06B | |
-9.99% | 861M | |
-4.54% | 858M |
- Stock Market
- Equities
- 1271 Stock
- Company SunWay Biotech Co., LTD.